Diamedica Therapeutics (DMAC)10% owner bought ~$1.4M

~$1.4M

Approx. value · 400K sh @ $3.50

4.96M

Holds after · shares reported

Traded

Jul 23, 2025

Filed

Jul 25, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jul 23, 2025 · this disclosureInsider10% owner purchased ~$1.4M of DMAC shares in the open market

What came next

1. Jul 23, 2025Insider · 2 peopleInsiders: 2 purchases (~$15.4M)
2. Aug 13, 2025Insider10% owner purchased ~$1.73M of DMAC shares in the open market
3. Aug 14, 2025Insider10% owner purchased ~$422K of DMAC shares in the open market
4. Aug 15, 2025Insider10% owner purchased ~$49K of DMAC shares in the open market
5. Aug 20, 2025Insider10% owner purchased ~$416K of DMAC shares in the open market
6. Aug 21, 2025Insider10% owner purchased ~$287K of DMAC shares in the open market
7. Aug 22, 2025Insider10% owner purchased ~$357K of DMAC shares in the open market
8. Aug 25, 2025Insider10% owner purchased ~$2.03M of DMAC shares in the open market
9. Aug 26, 2025Insider10% owner purchased ~$358K of DMAC shares in the open market
10. Aug 27, 2025Insider10% owner purchased ~$305K of DMAC shares in the open market
11. Nov 12, 2025Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Diamedica Therapeutics

OQRO holds no insider, Congress, fund or contract record for Diamedica Therapeutics dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DMAC page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Diamedica Therapeutics

• SEC Form 4Dec 8, 2025
• SEC Form 4Dec 8, 2025
• SEC Form 4Dec 8, 2025
• SEC Form 4Dec 8, 2025
• SEC Form 4Dec 8, 2025
• SEC Form 4Dec 8, 2025

Everything OQRO holds on this company is on its DMAC page.